Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
Xolatryp
Myocardial Ischemia and Arrhythmia Control
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
21-Nov-2022
Results of Meeting
21-Nov-2022
AGM Presentation by James Bonnar CEO
21-Nov-2022
Nyrada AGM 2022 Chairmans Address
18-Nov-2022
Nyrada Receives A$1.2M R&D Tax Incentive Rebate
27-Oct-2022
CEO Remuneration Update
26-Oct-2022
Quarterly Activities Report and Appendix 4C
18-Oct-2022
2022 AGM Letter to Shareholders and Proxy
18-Oct-2022
2022 AGM Notice of Meeting and Proxy
10-Oct-2022
Efficacy Study Published in Journal of Lipid Research
29-Sep-2022
Presentation to ShareCafe Hidden Gems Webinar
1
2
3
4
Next
